Greenwich Lifesciences Inc (GLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 28,660 | 7 | N/A | N/A |
| TOTAL | $28,660 | $7 | $N/A | $N/A |
| Non-Current Assets | ||||
| Intangibles | 16 | 20 | 0 | 0 |
| TOTAL | $16 | $20 | $N/A | $N/A |
| Total Assets | $28,677 | $27 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 711 | 730 | 0 | 0 |
| Other current liabilities | 335 | 647 | N/A | N/A |
| TOTAL | $1,046 | $1,377 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,046 | $1,377 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 12,847 | N/A | N/A | N/A |
| Common Shares | 13 | 9 | N/A | N/A |
| Retained earnings | -29,077 | -27,214 | N/A | N/A |
| TOTAL | $27,631 | $-1,350 | $N/A | $N/A |
| Total Liabilities And Equity | $28,677 | $27 | $0 | $0 |